Executive SummaryPatrick Zenner, Roche Labs senior VP-pharmaceuticals, is moving to corporate headquarters in Basel on two-year assignment as director of project management and drug regulatory affairs. Zenner, who was also a member of the Roche executive committee and board, will assume his new position Jan. 1, 1989. He will remain at the parent company for two years, to "facilitate and enhance cooperation and collaboration between Basel and Nutley (N.J.) in the critical areas related to international development and registration of pharmaceutical products," according to a Roche announcement of the move.
You may also be interested in...
Number one ask is for congressional pressure to centralize rare disease expertise at the agency, but advocates also are preparing legislation that would mandate the new center.
FDA’s food, dietary supplement and cosmetics division seeks funding to support its artificial intelligence capabilities, including post-market surveillance and speedy interventions in instances where safety issues arise. Also of note, the agency cites UV filters’ effects on the skin microbiome as a research priority in its fiscal 2021 budget justification to Congress.
Catering to patients can help make clinical trials more accessible and useful, presenters argued at a recent conference.